COVID-19 Antibody therapy


Pre-Exposure / Prophylactic

EVUSHELD is a combination of two long-acting monoclonal antibodies (LAAB) and is the only antibody therapy authorized in the U.S. for pre-exposure prophylactic (preventive) use against COVID-19 in immunocompromised patients. EVUSHELD therapy is administered in two quick intramuscular doses and provides up to a 77% reduction in the risk of COVID-19 infection for 6 months after administration.

8:30am – 2:30pm
  • Thursday March 3rd: 5:30pm – 9:00pm
  • Saturday March 5th: 2:00pm – 5:30pm
  • Monday March 7th: 5:30pm – 9:00pm
  • Wednesday March 9th: 5:30pm – 9:00pm
  • Monday March 21st: 5:30pm – 9:00pm
  • Wednesday March 23rd: 4:30pm – 8:00pm
  • Tuesday March 29th: 4:30pm – 8:00pm
  • Friday April 8th: 5:30pm – 9:00pm
  • Sunday April 10th: Time TBD